Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MAMAHT STUDY
PACTR202202608761158Phase 2Not yet recruiting
- Sponsor
- Dr Bello Ibrahim
- Start
- Feb 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of artemether + lumefantrine in malaria, sponsored by Dr Bello Ibrahim. Primary endpoint: Comparative reduction in parasite density with artemether + lumefantrine. Planned start Feb 2022; status: not yet recruiting.
02
Drugs
artemether + lumefantrine
03
Conditions
malaria
Beyond the preview
Go deeper on PACTR202202608761158.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202202608761158.